Enzootic intranasal adenocarcinoma (ENA) of goats are contagious tumoral disease that characterized occurrence of tumoral masses in nasal cavity of the animals. The etiological agent of the disease is retrovirus and the disease cause high economical loses in goat industry. Retroviruses, respectively inducing lung or nasal adenocarcinomas. The true economic impact of ENA is not known because affected animals are given insights from the herd before actual diagnosis, and suspected disease incidence is rarely reported. Telomerase regulates the proliferative capacity of cells and this enzyme has critical role in tumor progression. The aim of this study is to evaluate telomerase activity in serum and tumoral tissue in goat with ENA. For this aim 11 goat’s serum were analyses for telomerase activity. Tumoral tissue sections of totally 14 death goats were examined by immunohistochemically for telomerase expression. In addition, 10 normal goat’s serum and nasal tissues that belong slaughtered healthy animals used as control. This study showed that increased serum and tissue telomerase activity in goats with ENA comparing to controls. Also our results showed that telomerase activity becomes a useful prediction marker for tumor development in infected but clinically healthy goats in infected flocks
Keçilerin enzootik intranazal adenokarsinomu (ENA), hayvanların burun boşluğunda tümoral kitlelerin şekillenmesi ile karakterize bulaşıcı bir hastalıktır. Hastalığın etkeni retrovirüs olup, keçi endüstrisinde ekonomik kayıplara neden olmaktadır. Retroviruslar sırasıyla akciğer veya nazal adenokarsinomlara yol açar. Hastalıktaki ekonomik kayıp tam olarak bilinmemektedir. Çoğu zaman hasta hayvanlar teşhisten önce sürüden çıkarıldıkları için hastalığın gerçek insidansı ile ilgili bildirimler nadirdir. Telomeraz, hücrelerin proliferatif kapasitesini düzenler ve bu enzim tümörün yayılmasında kritik bir role sahiptir. Bu çalışmanın amacı ENA’lı keçilerin kan serumu ve tümöral dokularında telomeraz aktivitesini değerlendirmektir. Bu amaçla, 11 ENA’lı keçi serumunda telomeraz aktivitesi için analizler yapıldı. Ayrıca toplam 14 ölü keçinin tümoral doku kesitleri, telomeraz ekspresyonu için immunohistokimyasal olarak incelendi. Kontrol olarak, kesimi yapılan 10 sağlıklı keçinin serumu ve burun dokusu kullanıldı. Bu çalışmada ENA’lı keçilerde serum ve tümör dokularında telomeraz aktivitesinin kontrol grubundaki keçilere kıyasla arttığı tespit edildi. Enfekte olmuş fakat klinik olarak sağlıklı görünen keçilerde telomeraz aktivitesinin tümör gelişimi için yararlı bir belirteç olabileceği görüldü.
___
Hiyama E, Hiyama K, Yokoyama T, Shay JW: Immunohistochemical detection of telomerase (hTERT) protein in human cancer tissues and a subset of cells in normal tissues. Neoplasia, 3, 17-26, 2001. DOI: 10.1038/ sj.neo.7900134
Raghunandan BN, Sanjai K, Kumaraswamy J, Papaiah L, Pandey B, Jyothi BM: Expression of human telomerase reverse transcriptase protein in oral epithelial dysplasia and oral squamous cell carcinoma: An immunohistochemical study. J Oral Maxillofac Pathol, 20, 96-101, 2016. DOI: 10.4103/0973-029X.180953
Palani J, Lakshminarayanan V, Kannan R: Immunohistochemical detection of human telomerase reverse transcriptase in oral cancer and pre-cancer. Indian J Dent Res, 22, 362-363, 2011. DOI: 10.4103/0970- 9290.84281
Suzuki K, Shuto S, Miura Y, Sentsui H: Measurement of telomerase activity in bovine leukaemia virus infected cows. Vet Microbiol, 127, 142- 146, 2008. DOI: 10.1016/j.vetmic.2007.08.016
Pagnini U, De Martino L, Montagnaro S, Diodato A, Longo M, Pacelli F, Pisanelli G, Iovane G: Bovine herpesvirus type 1 (BHV-1) upregulates telomerase activity in MDBK cells. Vet Microbiol, 113, 231-236, 2006. DOI: 10.1016/j.vetmic.2005.11.006
Yazawa M, Okuda M, Setoguchi A, Iwabuchi S, Nishimura R, Sasaki N, Masuda K, Ohno K, Tsujimoto H: Telomere length and telomerase activity in canine mammary gland tumors. Am J Vet Res, 62, 1539-1543, 2001. DOI: 10.2460/ajvr.2001.62.1539
Cadile CD, Kitchell BE, Biller BJ, Hetler ER, Balkin RG: Telomerase activity as marker for malignancy in feline tissues. Am J Vet Res, 62, 1578- 1581, 2001. DOI: 10.2460/ajvr.2001.62.1578
Varon D, Jiang C, Hedican C, Dome JS, Umbricht CB, Carey LA, Thompson HJ, Sukumar S: Telomerase activity in the normal and neoplastic rat mammary gland. Cancer Res, 57, 5605-5609, 1997.
Argyle DJ, Nasir L: Telomerase: A potential diagnosis and therapeutic tool in canine oncology. Vet Pathol, 40, 1-7, 2003. DOI: 10.1354/vp.40-1-1
Kim NW, Pietyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, Coviello GM, Wright WE, Weinrich SL, Shay JW: Specific association of human telomerase activity with immortal cells and cancer. Science, 266, 2011-2015, 1994. DOI: 10.1126/science.7605428
Artandi SE, DePinho RA: Telomeres and telomerase in cancer. Carcinogenesis, 31, 9-18, 2010. DOI: 10.1093/carcin/bgp268
Nasir L, Devlin P, Mckevitt T, Rutteman G, Argyle DJ: Telomere lengths and telomerase activity in dog tissues: A potential model system to study human telomere and telomerase biology. Neoplasia, 3, 351-359, 2001. DOI: 10.1038/sj.neo.7900173
Blackburn EH: Structure and function of telomeres. Nature, 350, 569- 573, 1991. DOI: 10.1038/350569a0
Gorbunova V, Seluanov A: Telomerase as a growth-promoting factor. Cell Cycle, 2, 534-537, 2003. DOI: 10.4161/cc.2.6.515
Shay JW, Wright WE: Hallmarks of telomeres in ageing research. J Pathol, 211, 114-123, 2007. DOI: 10.1002/path.2090
Ozmen O, Sahinduran S, Haligur M, Demir N: Clinical, pathological, immunohistochemical and ultrastructural observations on enzootic nasal adenocarcinoma in five goats. Kafkas Univ Vet Fak Derg, 16, 633-639, 2010. DOI: 10.9775/kvfd.2009.1340
McKinnon AO, Thorsen J, Hayes MA, Misener CR: Enzootic nasal adenocarcinoma of sheep in Canada. Can Vet J, 23, 88-94, 1982.
Walsh SR, Linnerth-Petrik NM, Laporte AN, Menzies PI, Foster RA, Wootton SK: Full-length genome sequence analysis of enzootic nasal tumor virus reveals an unusually high degree of genetic stability. Virus Res, 151, 74-87, 2010. DOI: 10.1016/j.virusres.2010.04.002
Caswell J, Williams K: Enzootic nasal tumour of sheep. In, Maxie M (Ed): Jubb, Kennedy & Palmer’s Pathology of Domestic Animals. 5th ed., 640-643, Philadelphia, Elsevier Saunders, 2007.
De las Heras M, Ortin A, Cousens C, Minguijon E, Sharp JM: Enzootic nasal adenocarcinoma of sheep and goats. Curr Top Microbiol Immunol, 275, 201-223, 2003.
Leroux C, Mornex JF: Retroviral infections in sheep and the associated diseases. Small Ruminant Res, 76, 68-76, 2008. DOI: 10.1016/J. SMALLRUMRES.2007.12.010
Leroux C, Cruz JC, Mornex JF: SRLVs: A genetic continuum of lentiviral species in sheep and goats with cumulative evidence of cross species transmission. Curr HIV Res, 8, 94-100, 2010. DOI: 10.2174/ 157016210790416415
Fan XG, Huang Y, Tang FQ, Yi H: Telomerase activity of peripheral blood lymphocytes in patients with chronic hepatitis B. Immunol Lett, 73, 7-11, 2000. DOI: 10.1016/S0165-2478(00)00187-5
Chen F, Liu C, Lindvall C, Xu D, Ernberg I: Epstein-Barr virus latent membrane 2A (LMP2A) down-regulates telomerase reverse transcriptase (hTERT) in epithelial cell lines. Int J Cancer, 113, 284-289, 2005. DOI: 10.1002/ijc.20594
Franzese O, Comandini A, Adamo R, Sgadari C, Ensoli B, Bonmassar E: HIV-Tat down-regulates telomerase activity in the nucleus of human CD4+ T cells. Cell Death Differ, 11, 782-784, 2004. DOI: 10.1038/ sj.cdd.4401346
Yang CT, Song J, Bu X, Cong YS, Bacchetti S, Rennie P, Jia WW: Herpes simplex virus type-1 infection upregulates cellular promoters and telomerase activity in both tumor and nontumor human cells. Gene Ther, 10, 1494-1502, 2003. DOI: 10.1038/sj.gt.3302005
Djeraba-AitLounis A, Soubieux D, Klapper W, Rasschaert D: Induction of telomerase activity in avian lymphoblastoid cell line transformed by Marek’s disease virus, MDCC-MSB1. Vet Pathol, 41, 405- 407, 2004. DOI: 10.1354/vp.41-4-405
Verma SC, Borah S, Robertson ES: Latency-associated nuclear antigen of Kaposi’s sarcoma-associated herpesvirus upregulates transcription of human telomerase reverse transcriptase promoter through interaction with transcription factor Sp1. J Virol, 78, 10348-10359, 2004. DOI: 10.1128/JVI.78.19.10348-10359.2004
Yang J, Deng X, Deng L, Gu H, Fan W, Cao Y: Telomerase activation by Epstein-Barr virus latent membrane protein 1 is associated with c-Myc expression in human nasopharyngeal epithelial cells. J Exp Clin Cancer Res, 23, 495-506, 2004.
Shay JW, Wright WE: Role of telomeres and telomerase in cancer. Semin Cancer Biol, 21, 349-353, 2011. DOI: 10.1016/j.semcancer.2011.10.001
Dikmen GZ, Dikmen E, Doğan P: Kanserde telomeraza yönelik tedavi stratejileri. Hacettepe Tıp Der, 37, 49-55, 2006.
Chadeneau C, Hay K, Hirte HW, Gallinger S, Bacchetti S: Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res, 55, 2533-2536, 1995.
Bachor C, Bachor OA, Boukamp P: Telomerase is active in normal gastrointestinal mucosa and not up-regulated in precancerous lesions. J Cancer Res Clin Oncol, 125, 453-460, 1999. DOI: 10.1007/s004320050302
Kim NW: Clinical implication of telomerase in cancer. Eur J Cancer, 33, 781-786, 1997. DOI: 10.1016/S0959-8049(97)00057-9
Yıldız MG, Aras S, Duman DC: Telomerlerin yaşlanma ve kanser ilişkisindeki rolü. Türk Hij Den Biyol Derg, 66, 187-195, 2009.
Dikmen G, Doğan P: Telomeraz ve Kanser. T Klin Tıp Bilimleri, 23, 334- 341, 2003.
Collins K, Mitchell JR: Telomerase in the human organism. Oncogene, 21, 564-579, 2002. DOI: 10.1038/sj.onc.1205083
Chiu CP, Harley CB: Replicative senescence and cell immortality: The role of telomeres and telomerase. Proc Soc Exp Biol Med, 214, 99-106, 1997.
Richardson RB, Allan DS, Le Y: Greater organ involution in highly proliferative tissues associated with the early onset and acceleration of ageing in humans. Exp Gerontol, 55, 80-91, 2014. DOI: 10.1016/j. exger.2014.03.015
Al-Ajmi N, Saretzki G, Miles C, Spyridopoulos I: Dietary restriction ameliorates haematopoietic ageing independent of telomerase, whilst lack of telomerase and short telomeres exacerbate the ageing phenotype. Exp Gerontol, 58, 113-119, 2014. DOI: 10.1016/j.exger.2014.07.010